The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 22, 2023

Filed:

Aug. 23, 2018
Applicant:

Sulfateq B.v., Groningen, NL;

Inventors:

Robert Henk Henning, Groningen, NL;

Gerrit Jan Willem Euverink, Haren, NL;

Guido Krenning, Groningen, NL;

Adrianus Cornelis Van der Graaf, Groningen, NL;

Assignee:

SULFATEQ B.V., Groningen, NL;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/353 (2006.01); A61K 31/496 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 31/353 (2013.01); A61K 31/496 (2013.01); A61K 9/0053 (2013.01);
Abstract

The present invention relates to the (S) enantiomeric form of certain 6-chromanol derivatives for use as a medicament. Especially, the present invention relates to the (S) enantiomeric form of a 6-chromanol derivative for use as a medicament wherein said 6-chromanol derivative is chosen from the group consisting of (6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(piperazin-1-yl)methanone; N-(benzyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide; N-(phenyl)-6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamide; methyl 4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxamido)benzoate; (6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(morpholino)methanone, and pharmaceutically acceptable salts or bases thereof and pharmaceutically acceptable salts thereof.


Find Patent Forward Citations

Loading…